Study: Onconase, Malaria Drug Extends Mesothelioma Survival
A new treatment combining two existing drugs — one derived from frog eggs and another given to combat malaria — may be the key to extending mesothelioma survival. Scientists at Tongji University in Shanghai, China, discovered that mixing Onconase, an enzyme present in early-stage leopard frog embryos, with antimalarial drug dihydroartemisinin (DHA) synergistically suppressed growth…
The post Study: Onconase, Malaria Drug Extends Mesothelioma Survival appeared first on Mesothelioma Center – Vital Services for Cancer Patients & Families.